ClinicalTrials.Veeva

Menu

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (CTCVADS)

I

Institut de Cancérologie de Lorraine

Status

Completed

Conditions

Head and Neck Cancer

Treatments

Other: Circulating Tumor Cells

Study type

Interventional

Funder types

Other

Identifiers

NCT02892786
2010-A00586-33

Details and patient eligibility

About

The dissemination of individual tumor cells is a common phenomenon in solid cancers. Detection of tumor cells in peripheral blood circulating tumor cells (CTC) in nonmetastatic situation is of high prognostic significance.

The objective of our study was to detect circulating tumor cells in two different method in patient with head and neck squamous cell carcinoma .

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Patient with head and neck squamous cell cancer stage III or IV histologically proven
  • Patient naive to any prior therapy
  • Patient with operate cancer and resectable tumor
  • Hemoglobin ≥ 10g / dL
  • Performance status ≤ 2
  • Ability to provide written informed consent
  • Patient's legal capacity to consent to study participation

Exclusion criteria

  • Other previous histology tumors
  • Medical conditions or acute or chronic severe psychiatric disorders
  • Deprived of liberty or under supervision

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

experimental
Experimental group
Treatment:
Other: Circulating Tumor Cells

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems